FDA Import Refusal 799-1529121-4/11/1 — Natco Pharma Limited
The FDA refused shipment 799-1529121-4/11/1 from Natco Pharma Limited (India) on Apr 5, 2021. The refused product falls under Drugs and Biologics — MOXIFLOXACIN HCL (FLUOROQUINOLONE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Apr 5, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56OCA02 MOXIFLOXACIN HCL (FLUOROQUINOLONE)
- Charges
- 75